← Back to Discover
MWG Management Ltd.
Period ended Sep 30, 2025 · Latest filing Nov 12, 2025
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2025: $81,319,135
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2025. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- BEAM THERAPEUTICS INC · COM · 07373V105 · shares: $55,018,488
- LYELL IMMUNOPHARMA INC · COM NEW · 55083R203 · shares: $16,371,804
- PRIME MEDICINE INC · COM · 74168J101 · shares: $9,928,843
Reported holdings
3 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| BEAM THERAPEUTICS INC | COM | 07373V105 | — | 2,266,934 shares | $55,018,488 |
| LYELL IMMUNOPHARMA INC | COM NEW | 55083R203 | — | 1,008,116 shares | $16,371,804 |
| PRIME MEDICINE INC | COM | 74168J101 | — | 1,792,210 shares | $9,928,843 |